Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Patrik Olof DahlÚn
Age : 59
Public asset : 162,311 USD
Linked companies : ViroGates A/S
Summary 
Patrik Olof DahlÚn is a Finnish businessperson who has been at the head of 16 different companies.

He holds the position of Chairman at Visiopharm An and Chairman at Advalight ApS.

He is also on the board of ViroGates A, Immudex A, SSI Diagnostica A (former Co-Chief Executive Officer) and Byggvarulistan i Sverige AB.

In the past Dr. DahlÚn occupied the position of Chairman for Anapa Biotech A, Chairman of Denator AB, Chairman at Moleculink AB, Chief Executive Officer of NTG Nordic Transport Group A, Chief Executive Officer for Chempaq A, Chief Executive Officer for Immunovia AB, Senior Vice President of PerkinElmer, Inc. (United States) Chief Executive Officer & Executive Director at Immunodiagnostic Systems Holdings Ltd. President for PerkinElmer Life Sciences, Inc. and Head-Diagnostics Systems at Wallac Oy (which are all subsidiaries of PerkinElmer, Inc. (United States)), Chairman at Sophion Bioscience A, Chairman at Proxeon Biosystems ApS, President & Chief Executive Officer for Dako Denmark ApS, Chief Executive Officer of BioImage A, President & Chief Executive Officer for Dako Corp. and General Manager of EG&G Reticon.

Dr. DahlÚn received a doctorate from the University of Turku and a graduate degree from ┼bo Akademi University.


Current positions of Patrik Olof DahlÚn 
NameTitle Since
ViroGates A/S
(Biotechnology & Medical Research)
Independent Director 2022
Visiopharm A/S Chairman -
Advalight ApS Chairman -
Immudex A/S Director -
SSI Diagnostica A/S Director 2020
Byggvarulistan i Sverige AB Director -


Holdings of Patrik Olof DahlÚn 
NameEquities%Valuation
Immunovia AB (publ) (IMMNOV)
(Advanced Medical Equipment & Technology)
51,8600.23%162,311 USD


Patrik Olof DahlÚn: Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
More news


© 2022 People and Ownership :   
Patrik Olof DahlÚn : Connections